World's Best Scientists 2026 revealed!
Håkan Mellstedt

Håkan Mellstedt

D-Index & Metrics

Immunology

D-Index
82
Citations
21562
World Ranking
1523
National Ranking
28

Medicine

D-Index
83
Citations
22337
World Ranking
15737
National Ranking
287

Håkan Mellstedt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Håkan Mellstedt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 494 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Håkan Mellstedt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Håkan Mellstedt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Håkan Mellstedt is affiliated with the Karolinska Institute in Sweden and has contributed to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields including Oncology, Molecular Biology, Immunology, Genetics, and Hematology.

The scientist's main research topics cover Chronic Lymphocytic Leukemia Research, Phagocytosis and Immune Regulation, Chronic Myeloid Leukemia Treatments, Lung Cancer Research Studies, PI3K/AKT/mTOR signaling in cancer, Wnt/β-catenin signaling in development and cancer, and Acute Lymphoblastic Leukemia research.

Recent publications include:

  • Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia, 2020, PubMed
  • Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung, 2021, Cell Death and Disease
  • A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells, 2022, Pharmaceutics
  • A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib-resistant ROR1+ CLL cells, 2021, eJHaem
  • Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules, 2021, Handbook of experimental pharmacology

Frequent publication venues for the scientist include:

  • Pharmaceutics
  • eJHaem
  • PubMed
  • Cell Death and Disease
  • Journal of Hematology

Regular co-author collaborations feature the following researchers:

  • Mohammad Hojjat-Farsangi
  • Johan Schultz
  • Anders Österborg
  • Thomas Olin
  • Marzia Palma

Best Publications

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

    Jeanette Lundin;Eva Kimby;Magnus Björkholm;Per-Anders Broliden

  • Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

    A. Österborg;M. J. S. Dyer;D. Bunjes;G. A. Pangalis

  • Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

    Carlo Patriarca;Roberto Maria Macchi;Anja K. Marschner;Hakan Mellstedt

  • Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma

    Hiroshi Nakagomi;Max Petersson;Inger Magnusson;Claes Juhlin

  • INTERFERON THERAPY IN MYELOMATOSIS

    H Mellstedt;M Björkholm;B Johansson;A Ahre

  • The challenge of biosimilars.

    Hakan Mellstedt;D. Niederwieser;H. Ludwig

  • CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

    J Lundin;Anders Osterborg;G Brittinger;Derek Crowther

  • Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia.

    Anders ÖSterborg;Athanasios S. Fassas;Achilles Anagnostopoulos;Martin J. S. Dyer

  • Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

    Masanori Matsuda;Max Petersson;Rodica Lenkei;Jean-Luc Taupin

  • A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease

    Davide Bagnara;Matthew S. Kaufman;Matthew S. Kaufman;Matthew S. Kaufman;Carlo Calissano;Sonia Marsilio

  • Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell Responses

    Anders Österborg;Qing Yi;Lotta Henriksson;Jan Fagerberg

  • Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.

    Geoff Hale;Peppy Rebello;Lee R. Brettman;Chris Fegan

  • Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

    David J. McConkey;Miguel Aguilar-Santelises;Pia Hartzell;Ina Eriksson

  • A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes

    Staffan Paulie;Barbro Ehlin-Henriksson;Håkan Mellstedt;Hannu Koho

  • Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia

    L. Zech;G. Gahrton;L. Hammarström;G. Juliusson

  • Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

    Amir H. DaneshManesh;Eva Mikaelsson;Mahmood Jeddi‐Tehrani;Ali Ahmad Bayat

  • Monoclonal lymphocyte population in human plasma cell myeloma.

    H. Mellstedt;S. Hammarström;G. Holm

  • Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

    D. Killander;A. Dohlwitz;L. Engstedt;S. Franzén

  • Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

    Miguel Aguilar-Santelises;Martín E. Rottenberg;Nongnit Lewin;Håkan Mellstedt

Frequent Co-Authors

Anders Österborg
Anders Österborg Karolinska Institute
Magnus Björkholm
Magnus Björkholm Karolinska University Hospital
Mahmood Jeddi-Tehrani
Mahmood Jeddi-Tehrani Avicenna Research Institute
Bo Nilsson
Bo Nilsson Uppsala University
Peter Biberfeld
Peter Biberfeld Karolinska Institute
Mikael Jondal
Mikael Jondal Karolinska Institute
Giuseppe Masucci
Giuseppe Masucci Karolinska Institute
Britta Wahren
Britta Wahren Karolinska Institute
Rolf Kiessling
Rolf Kiessling Karolinska Institute
George Klein
George Klein Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open numerous career doors. Many students pursue accelerated paths such as ABSN programs, and finding absn programs with high acceptance rates can help simplify the admission process while advancing quickly toward nursing roles.

Similarly, those considering foundational nursing careers might explore LPN options. Programs highlighted in lpn programs with easiest admission requirements offer accessible entry points for students aiming to begin clinical work in healthcare settings without prohibitive entry barriers.

For advanced practice, nurse practitioner degrees are highly relevant. Identifying which nurse practitioner program is easiest can be crucial for students seeking programs that balance rigorous curriculum with flexible admission policies and efficient completion timelines.

Additionally, those passionate about mental health can specialize through programs such as the best psychiatric mental health nurse practitioner programs online. These options combine strong clinical placements with convenient online formats, preparing graduates for vital roles in psychiatric care.

Best Scientists Citing Håkan Mellstedt

Trending Scientists

Recently Published Articles